← Mechanisms of action
IGF1
SINGLE PROTEINHomo sapiens
Preferred name: Insulin-like growth factor I ChEMBL ↗
Linked proteins
Drugs acting on this target (9)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| bn201 | Activator | experimental | Small molecule | IGF1 activator |
| bezlotoxumab (zinplava) | Inhibitor | approved | mAb | IGF1 inhibitor |
| bi 836845 | Inhibitor | experimental | mAb | IGF1 inhibitor |
| dusigitumab | Inhibitor | experimental | mAb | IGF1 inhibitor |
| xentuzumab | Inhibitor | experimental | mAb | Insulin-like growth factor I inhibitor |
| mecasermin (Increlex) | Supplementation | approved | Recombinant protein | IGF1 supplementation |
| shp607 | Supplementation | experimental | Recombinant protein | IGF1 supplementation |
| vf001-dp | Supplementation | experimental | Recombinant protein | IGF1 supplementation |
| vmb-100 | Supplementation | experimental | Nucleic acid | IGF1 supplementation |